Dr. Manobianco specializes in the care of individuals at elevated risk for cancer, including those with hereditary cancer syndromes such as Hereditary Breast and Ovarian Cancer (HBOC), as well as in the treatment of patients with breast cancer. He is actively involved in the design and implementation of clinical trials, including both investigator-initiated studies and industry-sponsored research.
His academic interests center on precision oncology in breast cancer, with a particular focus on harnessing emerging technologies to enhance patient outcomes.